First Time Loading...

Amryt Pharma Holdings Ltd
LSE:AMYT

Watchlist Manager
Amryt Pharma Holdings Ltd Logo
Amryt Pharma Holdings Ltd
LSE:AMYT
Watchlist
Price: 143 GBX -11.73% Market Closed
Updated: May 7, 2024
Section:
 

Wall Street
Price Targets

AMYT Price Targets Summary
Amryt Pharma Holdings Ltd

There are no price targets for AMYT.
AMYT Lowest Forecast
Wall Street Target
Not Available
AMYT Average Forecast
Wall Street Target
Not Available
AMYT Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Amryt Pharma Holdings Ltd Competitors:
Price Targets
C
214370
Caregen Co Ltd
131% Upside
ERIS
Eris Lifesciences Ltd
25% Upside
688356
Jenkem Technology Co Ltd
33% Upside
Z
002332
Zhejiang Xianju Pharmaceutical Co Ltd
30% Upside
C
214370
Caregen Co Ltd
131% Upside
ERIS
Eris Lifesciences Ltd
25% Upside
688356
Jenkem Technology Co Ltd
33% Upside
Z
002332
Zhejiang Xianju Pharmaceutical Co Ltd
30% Upside
EOLS
Evolus Inc
70% Upside
4548
Seikagaku Corp
163% Upside
688578
Shanghai Allist Pharmaceuticals Co Ltd
43% Downside
G
002275
Guilin Sanjin Pharmaceutical Co Ltd
8% Upside

Revenue
Forecast

Revenue Estimate
Amryt Pharma Holdings Ltd

For the last 4 years the compound annual growth rate for Amryt Pharma Holdings Ltd's revenue is 229%. The projected CAGR for the next 5 years is 32%.

229%
Past Growth
32%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Amryt Pharma Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Amryt Pharma Holdings Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
AMYT intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMYT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMYT stock valuation using valuation multiples.
Wall Street Estimates
AMYT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMYT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AMYT's stock price target?
Not Available

AMYT doesn't have any price targets made by Wall Street professionals.

What is Amryt Pharma Holdings Ltd's Revenue forecast?
Projected CAGR
32%

For the last 4 years the compound annual growth rate for Amryt Pharma Holdings Ltd's revenue is 229%. The projected CAGR for the next 5 years is 32%.

ALPHA SPREAD
Join more than 134,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.